Two recent analyses provide new insight into the clinical efficacy of BCG versus chemotherapy with mitomycin C in intermediate-risk and high-risk bladder cancer. BCG immunotherapy showed a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback